Since the emergence of human H3N2 influenza A viruses in the pandemic of 1968, these
viruses have become established as strains of moderate severity. A decline in
virulence has been accompanied by glycan accumulation on the hemagglutinin globular
head, and hemagglutinin receptor binding has changed from recognition of a broad
spectrum of glycan receptors to a narrower spectrum. The relationship between
increased glycosylation, binding changes, and reduction in H3N2 virulence is not
clear. We evaluated the effect of hemagglutinin glycosylation on receptor binding
and virulence of engineered H3N2 viruses. We demonstrate that low-binding virus is
as virulent as higher binding counterparts, suggesting that H3N2 infection does not
require either recognition of a wide variety of, or high avidity binding to,
receptors. Among the few glycans recognized with low-binding virus, there were two
structures that were bound by the vast majority of H3N2 viruses isolated between
1968 and 2012. We suggest that these two structures support physiologically relevant
binding of H3N2 hemagglutinin and that this physiologically relevant binding has not
changed since the 1968 pandemic. Therefore binding changes did not contribute to
reduced severity of seasonal H3N2 viruses. This work will help direct the search for
factors enhancing influenza virulence.